FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3188903013> ?p ?o ?g. }

• W3188903013 endingPage "1827" @default.
• W3188903013 startingPage "1820" @default.
• W3188903013 abstract "There is a paucity of research on the impact of cancer treatment on the health-related quality of life (HRQOL) of adolescent and young adult (AYA) patients with cancer. Patient-reported outcomes (PROs) are self-report measures used to assess HRQOL and symptom burden. The extent to which PROs have been included in trials that include common AYA cancer types has not been previously assessed.Therapeutic phase 3 trials among common AYA cancer types (Hodgkin lymphoma, non-Hodgkin lymphoma, acute lymphoblastic leukemia, sarcomas, and germ cell tumors) initiated between 2007 and 2020 were identified on ClinicalTrials.gov. The proportions and characteristics of trials including a PRO endpoint were assessed. For comparison with an older population, the proportion of breast and colorectal therapeutic phase 3 trials including PRO endpoints were assessed.Eighty-seven studies met the inclusion criteria. Overall, 20.7% of therapeutic phase 3 AYA trials included a PRO endpoint, and only one trial published PRO data. Germ cell tumors (42.9%) and non-Hodgkin lymphoma (40%) trials had the highest proportions of PRO inclusion. The European Organization for Research and Treatment of Cancer generic, cancer-specific quality of life questionnaire was the most commonly used PRO measure; nevertheless, the measures used varied within and between cancer types. The proportion of trials including a PRO endpoint did not change significantly between 2007 to 2013 and 2014 to 2020 (18.6% vs 22.7%, P=.79).Few therapeutic phase 3 AYA cancer trials include PRO endpoints, fewer publish PRO data, and there is no homogeneity in the measures administered. Therapeutic trials represent an underused opportunity to capture PRO data in the AYA population with the goal of improving HRQOL outcomes." @default.
• W3188903013 created "2021-08-16" @default.
• W3188903013 creator A5000172588 @default.
• W3188903013 creator A5016271942 @default.
• W3188903013 creator A5026384060 @default.
• W3188903013 creator A5030279260 @default.
• W3188903013 creator A5044457816 @default.
• W3188903013 creator A5056341385 @default.
• W3188903013 creator A5062911712 @default.
• W3188903013 creator A5072107576 @default.
• W3188903013 date "2021-12-01" @default.
• W3188903013 modified "2023-10-15" @default.
• W3188903013 title "Inclusion of Patient-Reported Outcomes in Adolescent and Young Adult Phase III Therapeutic Trials: An Analysis of Cancer Clinical Trials Registered on ClinicalTrials.gov" @default.
• W3188903013 cites W1954780543 @default.
• W3188903013 cites W1975511800 @default.
• W3188903013 cites W2050679821 @default.
• W3188903013 cites W2067494708 @default.
• W3188903013 cites W2076499738 @default.
• W3188903013 cites W2087202287 @default.
• W3188903013 cites W2096870505 @default.
• W3188903013 cites W2100667077 @default.
• W3188903013 cites W2126285244 @default.
• W3188903013 cites W2152045194 @default.
• W3188903013 cites W2167571044 @default.
• W3188903013 cites W2167643701 @default.
• W3188903013 cites W2168448906 @default.
• W3188903013 cites W2329100337 @default.
• W3188903013 cites W2344792835 @default.
• W3188903013 cites W2407107555 @default.
• W3188903013 cites W2530607866 @default.
• W3188903013 cites W2568710942 @default.
• W3188903013 cites W2592227277 @default.
• W3188903013 cites W2620909270 @default.
• W3188903013 cites W2762027870 @default.
• W3188903013 cites W2765988210 @default.
• W3188903013 cites W2772759141 @default.
• W3188903013 cites W2793840497 @default.
• W3188903013 cites W2892098814 @default.
• W3188903013 cites W2897416913 @default.
• W3188903013 cites W2897838742 @default.
• W3188903013 cites W2902500338 @default.
• W3188903013 cites W2903959199 @default.
• W3188903013 cites W2905365274 @default.
• W3188903013 cites W2911580731 @default.
• W3188903013 cites W2951537042 @default.
• W3188903013 cites W2986193489 @default.
• W3188903013 cites W2995874200 @default.
• W3188903013 cites W3003402209 @default.
• W3188903013 cites W3003765125 @default.
• W3188903013 cites W3003917950 @default.
• W3188903013 cites W3084149091 @default.
• W3188903013 cites W3084627750 @default.
• W3188903013 cites W3086473620 @default.
• W3188903013 cites W3125560419 @default.
• W3188903013 cites W4240338964 @default.
• W3188903013 cites W4250968058 @default.
• W3188903013 cites W4376849475 @default.
• W3188903013 doi "https://doi.org/10.1016/j.jval.2021.06.012" @default.
• W3188903013 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8630401" @default.
• W3188903013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34838280" @default.
• W3188903013 hasPublicationYear "2021" @default.
• W3188903013 type Work @default.
• W3188903013 sameAs 3188903013 @default.
• W3188903013 citedByCount "11" @default.
• W3188903013 countsByYear W31889030132022 @default.
• W3188903013 countsByYear W31889030132023 @default.
• W3188903013 crossrefType "journal-article" @default.
• W3188903013 hasAuthorship W3188903013A5000172588 @default.
• W3188903013 hasAuthorship W3188903013A5016271942 @default.
• W3188903013 hasAuthorship W3188903013A5026384060 @default.
• W3188903013 hasAuthorship W3188903013A5030279260 @default.
• W3188903013 hasAuthorship W3188903013A5044457816 @default.
• W3188903013 hasAuthorship W3188903013A5056341385 @default.
• W3188903013 hasAuthorship W3188903013A5062911712 @default.
• W3188903013 hasAuthorship W3188903013A5072107576 @default.
• W3188903013 hasBestOaLocation W31889030131 @default.
• W3188903013 hasConcept C121608353 @default.
• W3188903013 hasConcept C126322002 @default.
• W3188903013 hasConcept C143998085 @default.
• W3188903013 hasConcept C159110408 @default.
• W3188903013 hasConcept C203092338 @default.
• W3188903013 hasConcept C2776694085 @default.
• W3188903013 hasConcept C2776938808 @default.
• W3188903013 hasConcept C2779951463 @default.
• W3188903013 hasConcept C2908647359 @default.
• W3188903013 hasConcept C535046627 @default.
• W3188903013 hasConcept C71924100 @default.
• W3188903013 hasConcept C99454951 @default.
• W3188903013 hasConceptScore W3188903013C121608353 @default.
• W3188903013 hasConceptScore W3188903013C126322002 @default.
• W3188903013 hasConceptScore W3188903013C143998085 @default.
• W3188903013 hasConceptScore W3188903013C159110408 @default.
• W3188903013 hasConceptScore W3188903013C203092338 @default.
• W3188903013 hasConceptScore W3188903013C2776694085 @default.
• W3188903013 hasConceptScore W3188903013C2776938808 @default.
• W3188903013 hasConceptScore W3188903013C2779951463 @default.
• W3188903013 hasConceptScore W3188903013C2908647359 @default.
• W3188903013 hasConceptScore W3188903013C535046627 @default.

• next